SCHEMBL4734993

SCHEMBL4734993

CS(=O)(=O)Oc1ccc(C2(Cc3ccc(F)c(Br)c3)NC(=S)NC2=O)cc1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.33
ADAM17 P78536 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4733752 0.89 ADAM17 (0.32) CA2ADAM17
SCHEMBL4734177 0.89 PPARA (0.31)
SCHEMBL4738186 0.89 CA12 (0.31) CA2
SCHEMBL4737146 0.87 TDP1 (0.36) CA2ADAM17
SCHEMBL4736892 0.86 CA2 (0.32) CA2
SCHEMBL5066412 0.84 MAOB (0.35) CA2ADAM17
SCHEMBL4736195 0.80 CA2 (0.33) CA2
SCHEMBL4736774 0.80 MEN1 (0.31) CA2
SCHEMBL4735347 0.79 ADAM17 (0.30) ADAM17
SCHEMBL4737598 0.78 ADAM17 (0.35) ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979324-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA Astra Zeneca AB (SE) 2008-10-15 EP disclosed
WO-2008076046-A1 NOVEL 2-AMINO-5, 5-DIARYL-IMIDAZOL-4-ONES ASTRAZENECA AB (SE) 2008-06-26 WO disclosed
WO-2007058602-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. ASTRAZENECA AB (SE) 2007-05-24 WO disclosed